Boston, MA headquartered global private equity investor Advent International will acquire a majority stake in Mumbai India-based Bharat Serums and Vaccines Limited. The acquisition is expected to close by the end of 2019.
Bharat Serums is a biopharmaceuticals company focussed on women’s healthcare, assisted reproductive treatment, and critical care and emergency medicine in India and emerging markets.
Advent has invested more than $600 million in five Indian businesses this year in sectors such as healthcare, consumer products and financial services. Shweta Jalan, managing director and India head at Advent said, “Advent’s high level of investment activity in India this year demonstrates the attractiveness of the market and our commitment to investing here.”
Last updated: December 26th, 2025
